Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1962 1
1963 1
1964 5
1965 1
1966 3
1967 2
1968 2
1969 2
1970 3
1971 3
1972 1
1974 9
1975 5
1976 5
1977 3
1978 4
1979 5
1980 5
1981 9
1982 3
1983 7
1984 8
1985 9
1986 12
1987 5
1988 15
1989 14
1990 19
1991 18
1992 14
1993 13
1994 16
1995 20
1996 24
1997 25
1998 24
1999 38
2000 29
2001 41
2002 43
2003 54
2004 50
2005 41
2006 31
2007 28
2008 35
2009 41
2010 38
2011 58
2012 78
2013 67
2014 37
2015 60
2016 46
2017 65
2018 75
2019 110
2020 108
2021 124
2022 103
2023 89
2024 60
2025 84
2026 44

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,807 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hoshikawa y[au] (349 results)?
Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial.
Yamashita Y, Morimoto T, Muraoka N, Oyakawa T, Umetsu M, Akamatsu D, Nishimoto Y, Sato Y, Takada T, Jujo K, Minami Y, Ogihara Y, Dohi K, Fujita M, Nishikawa T, Ikeda N, Hashimoto G, Otsui K, Mori K, Sueta D, Tsubata Y, Shoji M, Shikama A, Hosoi Y, Tanabe Y, Chatani R, Tsukahara K, Nakanishi N, Kim K, Ikeda S, Mo M, Yoshikawa Y, Kimura T; ONCO DVT Study Investigators. Yamashita Y, et al. Among authors: yoshikawa y. Circulation. 2023 Nov 21;148(21):1665-1676. doi: 10.1161/CIRCULATIONAHA.123.066360. Epub 2023 Aug 28. Circulation. 2023. PMID: 37638968 Free article. Clinical Trial.
Japanese Orthopaedic Association (JOA) clinical practice guidelines on the management of lateral epicondylitis of the humerus - Secondary publication.
Amako M, Arai T, Iba K, Ikeda M, Ikegami H, Imada H, Kanamori A, Namba J, Nishiura Y, Okazaki M, Soejima O, Tanaka T, Tatebe M, Yoshikawa Y, Suzuki K. Amako M, et al. Among authors: yoshikawa y. J Orthop Sci. 2022 May;27(3):514-532. doi: 10.1016/j.jos.2021.09.003. Epub 2021 Dec 16. J Orthop Sci. 2022. PMID: 34922804 Review.
Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy.
Amano M, Kitaoka H, Yoshikawa Y, Sakata Y, Dohi K, Tokita Y, Kato T, Matsushima S, Kitai T, Okada A, Furukawa Y, Tamura T, Hayashida A, Abe H, Ando K, Yuda S, Inoko M, Kadota K, Abe Y, Iwakura K, Kitamura T, Masuda J, Ohara T, Omura T, Tanigawa T, Nakamura K, Nishimura K, Izumi C; REVEAL-HCM Investigators. Amano M, et al. Among authors: yoshikawa y. JACC Heart Fail. 2025 Jun;13(6):1014-1026. doi: 10.1016/j.jchf.2024.12.006. Epub 2025 Mar 12. JACC Heart Fail. 2025. PMID: 40088231 Free article.
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: A Randomized Clinical Trial.
Izumi C, Amano M, Yoshikawa Y, Fukushima S, Yaku H, Eishi K, Sakaguchi T, Ohno N, Hiraoka A, Okada K, Saiki Y, Miura T, Komiya T, Minami M, Yamamoto H, Omae K; ENBALV Trial Investigators. Izumi C, et al. Among authors: yoshikawa y. Circ Cardiovasc Interv. 2025 Jul;18(7):e015108. doi: 10.1161/CIRCINTERVENTIONS.124.015108. Epub 2025 May 12. Circ Cardiovasc Interv. 2025. PMID: 40663622 Clinical Trial.
Acid-sensing ion channel 1a blockade reduces myocardial injury in rodent models of myocardial infarction.
Redd MA, Yoshikawa Y, Khan N, Waqar M, Saez NJ, Outhwaite JE, Russell JS, Hanna AD, Chiu HS, Er SY, Butcher NJ, Mardon K, Fraser JF, Smythe ML, Rash LD, Thomas WG, King GF, Reichelt ME, Palpant NJ. Redd MA, et al. Among authors: yoshikawa y. Eur Heart J. 2024 May 7;45(17):1571-1574. doi: 10.1093/eurheartj/ehad793. Eur Heart J. 2024. PMID: 38095341 No abstract available.
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Fujimoto S, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: yoshikawa y. Int J Clin Oncol. 2025 Jan;30(1):123-133. doi: 10.1007/s10147-024-02649-2. Epub 2024 Oct 28. Int J Clin Oncol. 2025. PMID: 39467994
Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.
Redd MA, Scheuer SE, Saez NJ, Yoshikawa Y, Chiu HS, Gao L, Hicks M, Villanueva JE, Joshi Y, Chow CY, Cuellar-Partida G, Peart JN, See Hoe LE, Chen X, Sun Y, Suen JY, Hatch RJ, Rollo B, Xia D, Alzubaidi MAH, Maljevic S, Quaife-Ryan GA, Hudson JE, Porrello ER, White MY, Cordwell SJ, Fraser JF, Petrou S, Reichelt ME, Thomas WG, King GF, Macdonald PS, Palpant NJ. Redd MA, et al. Among authors: yoshikawa y. Circulation. 2021 Sep 21;144(12):947-960. doi: 10.1161/CIRCULATIONAHA.121.054360. Epub 2021 Jul 15. Circulation. 2021. PMID: 34264749 Free article.
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
Komura K, Hirosuna K, Tokushige S, Tsujino T, Nishimura K, Ishida M, Hayashi T, Ura A, Ohno T, Yamazaki S, Nakamori K, Kinoshita S, Maenosono R, Ajiro M, Yoshikawa Y, Takai T, Tsutsumi T, Taniguchi K, Tanaka T, Takahara K, Konuma T, Inamoto T, Hirose Y, Ono F, Shiraishi Y, Yoshimi A, Azuma H. Komura K, et al. Among authors: yoshikawa y. Mol Cancer. 2023 Nov 18;22(1):185. doi: 10.1186/s12943-023-01897-6. Mol Cancer. 2023. PMID: 37980528 Free PMC article.
Germline BARD1 variants predispose to mesothelioma by impairing DNA repair and calcium signaling.
Novelli F, Yoshikawa Y, Vitto VAM, Modesti L, Minaai M, Pastorino S, Emi M, Kim JH, Kricek F, Bai F, Onuchic JN, Bononi A, Suarez JS, Tanji M, Favaron C, Zolondick AA, Xu R, Takanishi Y, Wang Z, Sakamoto G, Gaudino G, Grzymski J, Grosso F, Schrump DS, Pass HI, Atanesyan L, Smout J, Savola S, Sarin KY, Abolhassani H, Hammarström L, Pan-Hammarström Q, Giorgi C, Pinton P, Yang H, Carbone M. Novelli F, et al. Among authors: yoshikawa y. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2405231121. doi: 10.1073/pnas.2405231121. Epub 2024 Jul 11. Proc Natl Acad Sci U S A. 2024. PMID: 38990952 Free PMC article.
Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study.
Kiko T, Asano R, Yoshikawa Y, Endo H, Fujisaki S, Takano R, Akao M, Nishi N, Hayashi H, Ogata S, Kotoku A, Horinouchi H, Inoue Y, Ueda J, Seike Y, Tsuji A, Fukuda T, Nishimura K, Matsuda H, Ogo T. Kiko T, et al. Among authors: yoshikawa y. Eur Respir J. 2025 Jul 14;66(1):2402268. doi: 10.1183/13993003.02268-2024. Print 2025 Jul. Eur Respir J. 2025. PMID: 40049724 Free PMC article.
1,807 results